{"id":17,"date":"2026-08-17T12:53:22","date_gmt":"2026-08-17T12:53:22","guid":{"rendered":"https:\/\/peptide-doc.com\/learn\/tb-500\/"},"modified":"2026-09-02T19:41:50","modified_gmt":"2026-09-02T19:41:50","slug":"tb-500","status":"publish","type":"learn_article","link":"https:\/\/peptide-doc.com\/de\/learn\/tb-500\/","title":{"rendered":"TB-500"},"content":{"rendered":"<div class=\"placeholder-meta\">\n<strong>META-TITLE:<\/strong> [TODO: TB-500 \u2014 Thymosin Beta-4 Research Profile | Brand]<br \/>\n<strong>META-DESC:<\/strong> [TODO: TB-500 (Thymosin Beta-4) research overview \u2014 actin regulation, tissue repair mechanisms, dosing, safety.]\n<\/div>\n<p><span class=\"todo\">[TODO]<\/span> Hook \u2014 TB-500 as a synthetic fragment of Thymosin Beta-4, widely studied for tissue repair and recovery, originally identified in thymus gland<\/p>\n<div class=\"placeholder-img\">[IMAGE: TB-500 molecular structure \u2014 43 amino acid peptide visualization]<\/div>\n<h2>What is TB-500?<\/h2>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> Full name \u2014 TB-500, synthetic version of Thymosin Beta-4 (T\u03b24)<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Origin \u2014 naturally occurring 43-amino acid peptide, found in all human\/animal cells<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Key protein \u2014 primary G-actin sequestering peptide in mammalian cells<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Molecular weight \u2014 4921 Da<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Systemic action \u2014 unlike BPC-157, travels systemically to injury sites via bloodstream<\/li>\n<\/ul>\n<h2>Mechanism of Action<\/h2>\n<div class=\"placeholder-img\">[IMAGE: TB-500 mechanism diagram \u2014 actin polymerization, cell migration, angiogenesis pathways]<\/div>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> Actin regulation \u2014 sequesters G-actin, promotes cell migration and cytoskeletal reorganization<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Angiogenesis \u2014 robust new blood vessel formation, VEGF-independent pathway<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Anti-inflammatory \u2014 downregulates inflammatory cytokines, NF-\u03baB modulation<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Stem cell mobilization \u2014 promotes differentiation and migration to injury sites<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Anti-fibrotic \u2014 reduces scar formation, promotes functional tissue repair<\/li>\n<\/ul>\n<h2>Research Highlights<\/h2>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> Cardiac \u2014 post-MI cardiac repair, cardiomyocyte survival (mouse models)<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Dermal \u2014 accelerated wound closure, hair regrowth (animal models)<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Corneal \u2014 corneal wound healing, RegeneRx Phase 2 trials (RGN-259)<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Musculoskeletal \u2014 muscle fiber repair, reduced inflammation post-injury<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Neurological \u2014 CNS repair potential, remyelination studies<\/li>\n<\/ul>\n<h2>Dosing Protocols (Research Context)<\/h2>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> Loading phase \u2014 4-8mg per week for first 4-6 weeks<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Maintenance \u2014 2-4mg every 2 weeks<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Administration \u2014 subcutaneous or intramuscular, systemic distribution<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Storage \u2014 lyophilized, reconstitute with BAC water, refrigerate<\/li>\n<\/ul>\n<h2>Safety &amp; Considerations<\/h2>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> Tolerability \u2014 well-tolerated in animal studies, minimal reported side effects<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Cancer concern \u2014 theoretical: angiogenesis promotion could feed existing tumors<\/li>\n<li><span class=\"todo\">[TODO]<\/span> WADA \u2014 prohibited substance in competitive sports<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Human data \u2014 limited to T\u03b24 eye drop trials (RGN-259), systemic human data lacking<\/li>\n<\/ul>\n<h2>Frequently Asked Questions<\/h2>\n<div class=\"placeholder-faq\">[FAQ: What is the difference between TB-500 and Thymosin Beta-4?]<\/div>\n<div class=\"placeholder-faq\">[FAQ: Does TB-500 need to be injected near the injury site?]<\/div>\n<div class=\"placeholder-faq\">[FAQ: How long until effects are typically observed in research?]<\/div>\n<div class=\"placeholder-faq\">[FAQ: Is TB-500 safe to combine with BPC-157?]<\/div>\n<h2>Related Products<\/h2>\n<p><span class=\"todo\">[TODO]<\/span> Link to TB-500 product page + Healing &amp; Recovery category<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[META-DESC TODO: TB-500 research profile \u2014 Thymosin Beta-4 fragment, tissue repair, angiogenesis, dosing protocols.]<\/p>\n","protected":false},"featured_media":0,"template":"","learn_category":[3],"class_list":["post-17","learn_article","type-learn_article","status-publish","hentry","learn_category-healing-recovery"],"_links":{"self":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/17","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article"}],"about":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/types\/learn_article"}],"version-history":[{"count":1,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/17\/revisions"}],"predecessor-version":[{"id":40,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/17\/revisions\/40"}],"wp:attachment":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/media?parent=17"}],"wp:term":[{"taxonomy":"learn_category","embeddable":true,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_category?post=17"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}